Pediatric Oncology
About Pediatric Oncology
Childhood cancers are different from adult cancers in their types, causes and treatment. Survival has improved greatly, but cancer remains a leading cause of disease-related death in children, and survivors often face long-term effects.
The Pediatric Oncology session at Cancer Research 2027 covers research and care for children and young people with cancer. It connects closely with types of cancer, as leukaemias, brain tumours and sarcomas are common in children.
In many high-income countries, more than eight in ten children with cancer now survive, but survival is much lower in many other parts of the world. Children's cancers often grow quickly and need specialist care. Treatment must also protect a child's growth, learning and future health. Families need strong support throughout treatment and beyond.
Key Topics in Pediatric Oncology
• Childhood leukaemias and lymphomas
• Paediatric brain tumours
• Neuroblastoma, Wilms tumour and retinoblastoma
• Paediatric sarcomas
• Adolescent and young adult cancers
• Genetics of childhood cancer
• Reducing treatment toxicity
• Survivorship and late effects
• Psychosocial support for families
• Access to childhood cancer care worldwide
Recent Advances in Pediatric Oncology
Tumour sequencing in children is identifying targets for new treatments, linking with precision oncology. Cell therapies such as CAR-T have changed outcomes for some children with relapsed leukaemia, part of the progress in advances in cancer research and treatment.
Research is also focusing on reducing long-term side effects while keeping cure rates high. Ethical issues in trials with children are discussed in ethical considerations in cancer research and clinical trials.
International collaborations are helping improve care in countries with fewer resources. New targeted treatments and immunotherapies are offering hope for children whose cancer has returned. Survivorship clinics are helping young people manage long-term effects such as heart or fertility problems. Research is increasingly involving children and families in decisions about care.
Who Should Attend the Pediatric Oncology Session
• Paediatric oncologists and haematologists
• Paediatric surgeons and radiation oncologists
• Paediatric oncology nurses
• Childhood cancer researchers
• PhD students and early-career researchers
• Psychologists and family support professionals
Why Present Your Research in Pediatric Oncology
Presenting at Cancer Research 2027 lets you share childhood cancer research with an international audience. You can connect with colleagues in clinical research and clinical trials of cancer working on trials for children. Childhood cancer is rare, so sharing experience across countries is essential. Your work can directly help improve care for children elsewhere.
Frequently Asked Questions
Can I present survivorship research?
Yes. Survivorship and late effects are key topics.
Does this session include adolescent and young adult cancers?
Yes. Cancers in adolescents and young adults fit this session.
Where is Cancer Research 2027 held?
Cancer Research 2027 is held at Village Hotel Changi, Singapore, from 8 to 10 March 2027, with online participation.